Related Experiment Video
Updated: Aug 12, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Ritalin for nicotine withdrawal: Nesbitt's paradox revisited
M D Robinson1, G D Anastasio, J M Little
1Department of Family Practice, Carolinas Medical Center, Charlotte 28232, USA.
Addictive Behaviors
|July 1, 1995
Summary
Methylphenidate may help reduce nicotine withdrawal symptoms and make quitting smoking easier. This stimulant showed potential safety and efficacy in a small trial, warranting further placebo-controlled studies.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Trials
Background:
- Nicotine dependence remains a significant public health issue.
- Effective pharmacotherapies for smoking cessation are crucial.
- Methylphenidate is a central nervous system stimulant with potential applications beyond its primary indications.
Purpose of the Study:
- To investigate the efficacy and safety of methylphenidate (Ritalin) as a treatment for nicotine withdrawal symptoms.
- To assess the impact of methylphenidate on anxiety levels and physiological parameters during smoking cessation.
- To evaluate the preliminary success rate of smoking cessation with methylphenidate support.
Main Methods:
- An unblinded clinical trial involving 19 nicotine-dependent smokers undergoing abrupt cessation.
- Participants received a target daily dosage of 30 mg oral methylphenidate for 5 days post-cessation.
- Measurements included tobacco withdrawal, state anxiety, blood pressure, and pulse, assessed serially for 7 days.
Main Results:
- Significant increases in tobacco withdrawal and state anxiety were observed.
- However, a majority of completers (71%) reported significant withdrawal relief.
- 13 participants (76%) found the quit attempt easier than previous attempts.
- Twelve participants (63%) achieved confirmed abstinence at day 5.
- Methylphenidate did not adversely affect blood pressure or pulse, suggesting a favorable safety profile.
Conclusions:
- Methylphenidate demonstrated potential in alleviating nicotine withdrawal symptoms and facilitating smoking cessation attempts.
- The stimulant appeared safe, with no adverse effects on cardiovascular parameters.
- Further investigation in a placebo-controlled clinical trial is recommended to confirm these preliminary findings.
Related Concept Videos
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...